|
Drug Therapy, Other
Citations 361-370 of 1029 total displayed.
|
Past content
(since Mar 1998):
|
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Hean T. Ong; Jin S. Cheah
JAMA 2008; 300: 903-a-904-a.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Hervé Maisonneuve
JAMA 2008; 300: 903.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
- Joseph S. Ross; David S. Egilman; Harlan M. Krumholz
JAMA 2008; 300: 904-b-905-b.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
- Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 300: 904-a.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Peter A. Lachenbruch; Ronald Wasserstein
JAMA 2008; 300: 904.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
- Catherine D. DeAngelis; Phil B. Fontanarosa
JAMA 2008; 300: 905-906.
[Extract]
[Full text]
[PDF]
- Original Contributions
Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet
- Robert B. Saper; Russell S. Phillips; Anusha Sehgal; Nadia Khouri; Roger B. Davis; Janet Paquin; Venkatesh Thuppil; Stefanos N. Kales
JAMA 2008; 300: 915-923.
[Abstract]
[Full text]
[PDF]
- Preliminary Communications
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial
- Daniel I. Feig; Beth Soletsky; Richard J. Johnson
JAMA 2008; 300: 924-932.
[Abstract]
[Full text]
[PDF]
- Commentaries
Opportunities for Enhancing the FDA Guidance on Pharmacovigilance
- Bruce M. Psaty; Jan P. Vandenbroucke
JAMA 2008; 300: 952-954.
[Extract]
[Full text]
[PDF]
- Letters
Pioglitazone vs Glimepiride in the PERISCOPE Trial
- Rahman Shah
JAMA 2008; 300: 787-a-788-a.
[Extract]
[Full text]
[PDF]
|
|
